SAFETY OF DARATUMUMAB IN FRAIL PATIENTS WITH MULTIPLE MYELOMA
Introduction: Frailty in elderly is associated with negative outcomes and high mortality. In frail patients diagnosed with Multiple Myeloma (MM), it's advisable to adjust the dosages of antineoplastic treatments to minimize associated toxicities. Objective: This study aims to present two clinic...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-10-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137923009744 |